-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Extrapyramidal symptoms (EPS) are a common feature of Alzheimer's disease (AD).
Based on a racially diverse community cohort, EPS was found to predict a faster rate of cognitive decline.
In this way, Anton J.
The core hypothesis: Compared with those without EPS, the risk of death, increased cognitive and dysfunction, and increased demand for full-time care for people with moderate EPS at baseline will increase significantly.
Compared with those without EPS, the risk of death, increased cognitive and dysfunction, and increased demand for full-time care for people with moderate EPS at baseline will increase significantly.
They found that 37 participants (26.
.
Original source:
ncbi.
ncbi.
nlm.
nih.
gov/33710771/" target="_blank" rel="noopener">Kociolek, Anton J.
, et al.
"Extrapyramidal signs and Alzheimer's disease prognosis in a multiethnic, community-based sample of demented elders.
" _Alzheimer's & Dementia_ (2021).
Leave a message here